Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies.
Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies.
复制标题
DOI:
10.1038/nchem.2463
复制
发表时间:
2016-04
期刊:
影响因子:
21.8
通讯作者:
Wong CH
中科院分区:
文献类型:
--
作者:
Shivatare SS;Chang SH;Tsai TI;Tseng SY;Shivatare VS;Lin YS;Cheng YY;Ren CT;Lee CC;Pawar S;Tsai CS;Shih HW;Zeng YF;Liang CH;Kwong PD;Burton DR;Wu CY;Wong CH
A new class of broadly neutralizing antibodies (bNAbs) from HIV donors has been reported to target the glycans on gp120, thus renewing hope of developing carbohydrate-based HIV vaccines. However, the version of gp120 used in previous studies was not from human T cells and so the glycosylation pattern could be somewhat different to that found in the native system. Moreover, some antibodies recognized two different glycans simultaneously and this cannot be detected with the commonly used glycan microarrays on glass slides. Here, we have developed a glycan microarray on an aluminium oxide-coated glass slide containing a diverse set of glycans, including homo- and mixed N-glycans (high-mannose, hybrid and complex types) that were prepared by modular chemo-enzymatic methods to detect the presence of hetero-glycan binding behaviours. This new approach allows rapid screening and identification of optimal glycans recognized by neutralizing antibodies, and could speed up the development of HIV-1 vaccines targeting cell surface glycans.